Securian Asset Management’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Buy
19,605
+2,434
+14% +$38.4K 0.01% 783
2026
Q1
$246K Buy
17,171
+2,057
+14% +$34.1K 0.01% 854
2025
Q4
$267K Buy
15,114
+1,974
+15% +$32.6K 0.01% 845
2025
Q3
$207K Buy
13,140
+1,467
+13% +$20.6K 0.01% 895
2025
Q2
$130K Buy
11,673
+111
+1% +$1.3K ﹤0.01% 924
2025
Q1
$135K Hold
11,562
﹤0.01% 924
2024
Q4
$158K Sell
11,562
-317
-3% -$4.59K ﹤0.01% 919
2024
Q3
$198K Buy
11,879
+1,946
+20% +$28.4K 0.01% 902
2024
Q2
$118K Sell
9,933
-245
-2% -$2.8K ﹤0.01% 924
2024
Q1
$122K Buy
10,178
+1,900
+23% +$28.3K ﹤0.01% 920
2023
Q4
$139K Sell
8,278
-100
-1% -$1.42K ﹤0.01% 922
2023
Q3
$126K Sell
8,378
-430
-5% -$7.25K ﹤0.01% 926
2023
Q2
$166K Sell
8,808
-116
-1% -$1.84K ﹤0.01% 926
2023
Q1
$160K Sell
8,924
-100
-1% -$1.67K ﹤0.01% 924
2022
Q4
$75.2K Hold
9,024
﹤0.01% 935
2022
Q3
$62K Hold
9,024
﹤0.01% 934
2022
Q2
$177K Buy
+9,024
New +$189K ﹤0.01% 948

Other funds holding SHC

Securian Asset Management's SHC Position: Q2 2026 in Review

Securian Asset Management increased its Sotera Health (SHC) stake by 14% in Q2 2026, buying an estimated $38.4K and bringing the position to 19,605 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #783.

Securian Asset Management first reported a position in SHC in Q2 2022 and has held it in 17 quarters since. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Securian Asset Management held 19,605 shares of Sotera Health worth $348K as of Q2 2026.
  • Securian Asset Management bought 2,434 Sotera Health shares in Q2 2026, an estimated $38.4K.
  • Sotera Health made up 0.01% of Securian Asset Management's portfolio in Q2 2026, its #783 holding.
  • Securian Asset Management first reported a position in Sotera Health in Q2 2022 and has held it in 17 quarters since.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.